Featured Research

from universities, journals, and other organizations

New approaches to understanding infection may uncover novel therapies against influenza

Date:
July 4, 2013
Source:
Seattle Biomedical Research Institute (Seattle BioMed)
Summary:
The influenza virus’ ability to mutate quickly has produced new, emerging strains that make drug discovery more critical than ever. For the first time, researchers have mapped how critical molecules regulate both the induction and resolution of inflammation during flu infection.

The influenza virus' ability to mutate quickly has produced new, emerging strains that make drug discovery more critical than ever. For the first time, researchers at Seattle BioMed, along with collaborators at the University of California, San Diego School of Medicine, St. Jude Children's Research Hospital and the University of Washington, have mapped how critical molecules regulate both the induction and resolution of inflammation during flu infection.

The results are published this month in the journal Cell.

Flu is an elusive foe

The influenza virus mutates extremely quickly, with different strains causing seasonal epidemics each year. Genetic shuffling between different viruses can increase influenza's ability to spread, causing devastating epidemics and pandemics. The 1918 flu pandemic, the first to involve the H1N1 strain, cost the lives of 50 to 100 million people, and even a typical flu season can cost as many as 50,000 lives a year.

Vaccines are a highly effective way to combat the flu, but because manufacturing and distributing vaccines takes such a long time, it is impossible for public health officials to wait until they know for certain which strain of flu will prevail in a given season. "Because of this, drugs are critically important to combat flu infections," says Alan Aderem, Ph.D., principal investigator on the research. "But at the moment, we have very few drugs at our disposal, and resistance is already beginning to appear against our limited arsenal."

Systems biology yielding new insights

The solution for Aderem and scientist Vincent Tam, Ph.D., was to take a systems approach to better understand the interactions between the flu virus and the human host. They teamed up with Oswald Quehenberger, Ph.D., and Edward Dennis, Ph.D., of the University of California, San Diego School of Medicine to tackle this problem. Systems biology uses computational tools to integrate the study of genes, proteins and lipids. This comprehensive approach unravels the complexities and provides a holistic view of the host-pathogen interaction. This strategy, focusing on lipid components, had never before been applied to the flu infection.

There is a class of lipid mediators that act as signaling molecules to control inflammation, and have long been known to play a role in stimulating an inflammatory response. "But some of these regulatory lipids, including ones derived from the omega-3 fatty acids and known as DHA and EPA, are also involved in resolving inflammation and bringing the body back to homeostasis," observed Quehenberger and Dennis. This dual role makes lipid mediators a critical player in the interaction between the virus and the human immune system.

The research team studied 141 different lipid metabolites and incorporated them into networks comprising lipids, genes and proteins of host responses to two different strains of the flu virus, one mild and one severe. In doing so, they found that infection by the mild H3N2 strain induced a pro-inflammatory response followed by a distinct anti-inflammatory response. This represented a case of a clearly regulated inflammatory response. In contrast, infection by the severe H1N1 strain resulted in overlapping pro- and anti-inflammatory states, indicating that the virus had disturbed the normal methods of controlling inflammation.

Importantly, the study discovered that many of the results found in the mouse model were recapitulated in humans by studying nasal wash samples collected from flu-infected patients. "It is absolutely crucial to confirm the relevance of these molecules in humans if we want to look for effective therapeutics against flu," says Aderem.

Moving to new interventions

"Once an infection starts, it's too late for vaccines," says Dennis, explaining the urgent need for drugs to combat the influenza virus. Emerging strains like H5N1 and H7N9 -- more commonly known as bird flu -- are especially dangerous, killing about 60% of the people they infect, according to data from the Centers for Disease Control and Prevention. Because drugs fight infections that are already underway, they are a critical player in keeping the multitude of flu strains under control.

A more complete understanding of how the flu virus interacts with the human immune system, including the role of lipid mediators, could reveal important new drug targets. "If we can perturb the balance between pro- and anti-inflammatory responses in flu patients, we can help them regulate their immune systems to control their infections," says Tam.

Research reported in this press release was supported by the National Institute of General Medical Sciences of the National Institutes of Health under award number U54GM069338, as well as the National Institute of Allergy and Infectious Diseases contract HHSN272200800058C "A Systems Biology Approach to Infectious Disease Research" and the National Institutes of Health/National Institute of Allergy and Infectious Diseases contract HHSN266200700005C.


Story Source:

The above story is based on materials provided by Seattle Biomedical Research Institute (Seattle BioMed). Note: Materials may be edited for content and length.


Journal Reference:

  1. VincentC. Tam, Oswald Quehenberger, ChristineM. Oshansky, Rosa Suen, AaronM. Armando, PiperM. Treuting, PaulG. Thomas, EdwardA. Dennis, Alan Aderem. Lipidomic Profiling of Influenza Infection Identifies Mediators that Induce and Resolve Inflammation. Cell, 2013; 154 (1): 213 DOI: 10.1016/j.cell.2013.05.052

Cite This Page:

Seattle Biomedical Research Institute (Seattle BioMed). "New approaches to understanding infection may uncover novel therapies against influenza." ScienceDaily. ScienceDaily, 4 July 2013. <www.sciencedaily.com/releases/2013/07/130704094347.htm>.
Seattle Biomedical Research Institute (Seattle BioMed). (2013, July 4). New approaches to understanding infection may uncover novel therapies against influenza. ScienceDaily. Retrieved October 20, 2014 from www.sciencedaily.com/releases/2013/07/130704094347.htm
Seattle Biomedical Research Institute (Seattle BioMed). "New approaches to understanding infection may uncover novel therapies against influenza." ScienceDaily. www.sciencedaily.com/releases/2013/07/130704094347.htm (accessed October 20, 2014).

Share This



More Health & Medicine News

Monday, October 20, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

How Nigeria Beat Its Ebola Outbreak

How Nigeria Beat Its Ebola Outbreak

Newsy (Oct. 20, 2014) The World Health Organization has declared Nigeria free of Ebola. Health experts credit a bit of luck and the government's initial response. Video provided by Newsy
Powered by NewsLook.com
Another Study Suggests Viagra Is Good For The Heart

Another Study Suggests Viagra Is Good For The Heart

Newsy (Oct. 20, 2014) An ingredient in erectile-dysfunction medications such as Viagra could improve heart function. Perhaps not surprising, given Viagra's history. Video provided by Newsy
Powered by NewsLook.com
Ebola Worries End for Dozens on U.S. Watch Lists

Ebola Worries End for Dozens on U.S. Watch Lists

Reuters - US Online Video (Oct. 20, 2014) Forty-three people who had contact with Thomas Eric Duncan, the first person diagnosed with Ebola in the U.S., were cleared overnight of twice-daily monitoring after 21 days of showing no symptoms. Rough Cut (no reporter narration). Video provided by Reuters
Powered by NewsLook.com
Fauci: Ebola Protocols to Focus on Training

Fauci: Ebola Protocols to Focus on Training

AP (Oct. 20, 2014) Dr. Anthony Fauci, head of the National Institute of Allergy and Infectious Diseases, says he expects revised CDC protocols on Ebola to focus on training, observation and ensuring health care workers are more protected. (Oct. 20) Video provided by AP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins